HMD · ASX

HeraMED Ltd (ASX:HMD)

AU$0.017

 -0.001 (-5.556%)
ASX:Live
09/05/2025 10:05:24 AM
HALO Price Momentum HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

HMD Overview

HMD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About HMD

Website

N/A

Telephone

61.2.7251.1888

Address

Suite 4, Level 16 55 Clarence Street Sydney, New South Wales (NSW) 2000

Description

N/A

HMD Price Chart

Key Stats

Market Cap

AU$13.30M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.03

Trade Value (12mth)

AU$5,215.00

1 week

5.88%

1 month

28.57%

YTD

-10%

1 year

2.86%

All time high

0.33

Key Fundamentals

EPS 3 yr Growth

-75.80%

EBITDA Margin

%

Operating Cashflow

-$5m

Free Cash Flow Return

-278.70%

ROIC

-317.80%

Interest Coverage

-108.50

Quick Ratio

3.20

Other Data

Shares on Issue (Fully Dilluted)

876m

HALO Sector

Technology

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

HMD Announcements

Latest Announcements

Date Announcements

30 April 25

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

28 April 25

Letter to Shareholders, Notice of AGM & Proxy Form

×

Letter to Shareholders, Notice of AGM & Proxy Form

07 April 25

Notification of Date of AGM

×

Notification of Date of AGM

18 March 25

HeraMED to present at NWR Virtual Healthcare Conference

×

HeraMED to present at NWR Virtual Healthcare Conference

28 February 25

Preliminary Final Report

×

Preliminary Final Report

28 February 25

Annual Report to shareholders

×

Annual Report to shareholders

28 February 25

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

25 February 25

Strategic Collaboration Agreement with Garmin Health

×

Strategic Collaboration Agreement with Garmin Health

19 February 25

Investor presentation

×

Investor presentation

18 February 25

Notification regarding unquoted securities - HMD

×

Notification regarding unquoted securities - HMD

18 February 25

Change of Director's Interest Notice - AG

×

Change of Director's Interest Notice - AG

31 January 25

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

31 December 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

24 December 24

Application for quotation of securities - HMD

×

Application for quotation of securities - HMD

24 December 24

Application for quotation of securities - HMD

×

Application for quotation of securities - HMD

24 December 24

Notification regarding unquoted securities - HMD

×

Notification regarding unquoted securities - HMD

23 December 24

Extension of Prospectus Closing Date

×

Extension of Prospectus Closing Date

20 December 24

Cleansing Prospectus

×

Cleansing Prospectus

19 December 24

Results of Meeting

×

Results of Meeting

17 December 24

Healthcare Technology Expert Advisory Board Appointment

×

Healthcare Technology Expert Advisory Board Appointment

04 December 24

Investor presentation

×

Investor presentation

26 November 24

LOI with Metronomic to develop postpartum care in US

×

LOI with Metronomic to develop postpartum care in US

20 November 24

Letter to Shareholders/Notice of General Meeting/Proxy Form

×

Letter to Shareholders/Notice of General Meeting/Proxy Form

11 November 24

HeraMED completes further $1million placement

×

HeraMED completes further $1million placement

11 November 24

Proposed issue of securities - HMD

×

Proposed issue of securities - HMD

HMD Fundamentals

Per Share Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.03 -0.03 -0.01 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.03 -0.03 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.4 21.1 59.4 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.01 -0.02 -0.01 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.02 -0.02 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 43.8 -33.7 69.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -13.8 -91.4 -45.3 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.02 0.00 0.00 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.01 -0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 295.3 -107.4 389.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 219 266 532 Lock Lock Lock
Basic m Lock Lock Lock Lock 219 266 532 Lock Lock Lock

Financial Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales AU$m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 173.5 92.0 -39.9 Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 4 6 5 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.7 4.6 64.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -99.5 -49.4 -29.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 199 149 130 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -4 -6 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.7 -47.5 12.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,289.3 -990.7 -1,438.8 Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -5 -7 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.6 -45.3 16.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,453.0 -1,100.1 -1,528.4 Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -7 -7 -5 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -7 -7 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.4 3.8 19.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,229.5 -1,117.6 -1,507.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock -4 -6 -5 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock -1 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 4 3 7 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock -4 -6 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.6 -54.4 15.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -11.7 -9.4 -13.2 Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 4 1 3 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 6 3 4 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock -4 -1 -3 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 1 2 1 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 4 1 3 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4 1 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2,994.7 -83.7 303.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -114.9 -229.4 -122.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -166.8 -987.6 -198.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -101.5 -245.7 -293.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -345.6 -276.2 -317.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -181.3 -232.9 -278.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -1.6 -44.5 -108.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.9 0.1 0.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -85.2 -116.8 -109.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.9 1.3 3.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.6 1.0 3.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 86.0 55.1 84.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -317.0 -379.5 -456.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.9 2.1 1.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 3.4 2.9 1.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 1.4 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 99.8 59.9 83.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.2 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.2 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -2,229.5 -1,117.6 -1,507.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -114.9 -229.4 -122.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -114.9 -229.4 -122.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.5 4.3 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -166.8 -987.6 -198.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -166.8 -987.6 -198.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 108.5 123.8 284.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 191.6 174.7 248.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 300.1 298.5 533.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 166.9 136.7 251.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 133.2 161.8 282.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

HMD Shortsell

Frequently Asked Questions

The current share price of HeraMED Ltd (HMD:ASX) is AU$0.017.
The 52-week high share price for HeraMED Ltd (HMD:ASX) is AU$0.03.
The 52-week low share price for HeraMED Ltd (HMD:ASX)? is AU$0.01.
HeraMED Ltd (HMD:ASX) does not pay a dividend.
HeraMED Ltd (HMD:ASX) does not pay a dividend.
HeraMED Ltd (HMD:ASX) has a franking level of 0.0%.
HeraMED Ltd (HMD:ASX) is classified in the Technology.
The current P/E ratio for HeraMED Ltd (HMD:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.